MedDataX Logo

Community Health Worker Reduces Care Utilization

NCT00711152 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 661

Last updated 2015-09-09

No results posted yet for this study

Summary

1. To recruit 600 type 2 diabetic patients managed in a community setting.
2. To enrol into the Joint Asia Diabetes Evaluation (JADE) Program.
3. All patients will undergo annual comprehensive assessment (CA) at a diabetes centre with personalized JADE report (JADE) at basline. Half of the randomized patients will be managed with additional support by a trained community health worker (CHW) (JADE+CHW).
4. All patients will undergo annual comprehensive assessments for comparison of attainment of treatment targets for 3 years

Conditions

  • Type 2 Diabetes Mellitus

Interventions

OTHER

Protocol-driven care under JADE Program

The JADE Program uses the state of the art of information technology to facilitate evidence-based clinical protocol by a multidisciplinary team. There is an internet on-line and computer record system to facilitate the day-to-day management of people with diabetes.

OTHER

Additional support by CHW

Patients will receive additional support by a trained community health worker (CHW). Guided by the personalized report with embedded decision support, the CHW will reinforce treatment adherence and self care after each clinic visit.

Sponsors & Collaborators

  • Asia Diabetes Foundation

    collaborator OTHER

  • Chinese University of Hong Kong

    lead OTHER

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2014-03-31
Completion
2014-03-31

Countries

  • Hong Kong

Study Locations

Related Clinical Trials

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00711152 on ClinicalTrials.gov